Localized Blistering Eruption of the Face and Neck – A Case Study and Differential Considerations

References

• Nguyen Q, Foster CS. Cicatricial pemphigoid: diagnosis and treatment. Int Ophthalmol Clin. 1996;36(1):41–60. doi:10.1097/00004397-199603610-00007
   PubMedGoogle Scholar
• Buonavoglia A, Leone P, Dammacco R, et al. Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy. Autoimmun Rev. 2019;18(4):349–358. doi:10.1016/j.autrev.2019.02.005
   PubMed Web of Science ®Google Scholar
• Ayvaz H, Gönül M, Atay S. Bullous Systemic Lupus Erythematosus and Cicatricial Pemphigoid. Intechopen; 2018. doi:10.5772/intechopen.74069
   Google Scholar
• Garcia-Martin P, Franga J, Hashimoto T, et al. Brunsting–Perry-type cicatricial pemphigoid with IgG autoantibodies to LAD-1. Br J Dermatol. 2014;170:735–758. doi:10.1111/bjd.12677
   PubMed Web of Science ®Google Scholar
• Daniel DS, Murrel DF. Review of autoimmune blistering diseases: the Pemphigoid diseases. J Eur Acad Dermatol Venerol. 2019;33(9):1685–1694. doi:10.1111/jdv.15679
   PubMed Web of Science ®Google Scholar
• Sato-Shibuya M, Dainichi T, Egawa G, et al. Case with Brunsting–Perry-like localized subepidermal blister formations and immunoglobulin G antibodies against unidentified basement membrane zone antigen. J Dermatol. 2016;43:426–428. doi:10.1111/1346-8138.13084
   PubMed Web of Science ®Google Scholar
• Contestable JJ, Edhegard KD, Meyerle JH. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. Am J Clin Dermatol. 2014;15:517–524. doi:10.1007/s40257-014-0098-0
   PubMed Web of Science ®Google Scholar
• Brunsting LA, Perry HO. Benign Pemphigoid? A report of seven cases with chronic, scarring, herpetiform plaques about the head and neck. AMA Arch Derm. 1957;75(4):489–501. doi:10.1001/archderm.1957.01550160015002
   PubMedGoogle Scholar
• Graham JH, MacVicar DN. Bullous dermatosis. In: Graham JH, Johnson WC, Helwig EF, editors. Dermal Pathology. Hagerstown, Md: Harper & Row Publishers Inc; 1972:269–323.
   Google Scholar
• Leenutaphong V, von Kries R, Plewig G. Localized cicatricial pemphigoid (Brunsting-Perry): electron microscopic study. J Am Acad Dermatol. 1989;21:1089–1093. doi:10.1016/S0190-9622(89)70302-9
   PubMed Web of Science ®Google Scholar
• Osipowicz K, Jakubowska B, Kowalewski C, Hashimoto T, Wozniak K. Laser scanning confocal microscopy for diagnostics of Brunsting-Perry type cicatricial pemphigoid cases, along with review of literature. J Clin Exp Dermatol Res. 2019;10:479.
   Google Scholar
• Michel B, Bean SF, Chorzelski T, Fedele CF. Cicatricial pemphigoid of Brunsting-Perry: immunofluorescent studies. Arch Dermatol. 1977;113:1403–1405. doi:10.1001/archderm.1977.01640100081015
   PubMedGoogle Scholar
• Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370–379. doi:10.1001/archderm.138.3.370
   PubMed Web of Science ®Google Scholar
• Imstepf V, Cazzaniga S, Beltraminelli H, Borradori L, Feldmeyer L. Brunsting-Perry pemphigoid: a retrospective case series of a frequently unrecognized condition. J Am Acad Dermatol. 2020;20:S0190-9622(20)32841–3.
   Google Scholar
• Jedlickova H, Niedermeier A, Zgazrova S, et al. Brunsting-Perry pemphigoid of the scalp with antibodies against laminin 332. Dermatology. 2011;222:193–195. doi:10.1159/000322842
   PubMed Web of Science ®Google Scholar
• Iranzo P, Herrero C, Castro J, et al. Penfigoide cicatrizal de Brunsting-Perry. Actas Dermo-Sif. 1979;70:430–434.
   PubMedGoogle Scholar
• Walling HW, Sontheimer RD. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol. 2009;10:365–381. doi:10.2165/11310780-000000000-00000
   PubMed Web of Science ®Google Scholar
• Reis Gavazzoni Dias M, Vilar Gedes Aparecid E, Beneto de Oliviera C, et al. Brunsting-Perry type pemphigoid causing secondary cicatricial alopecia in 2 patients. Skin Appendage Disord. 2018;4(4):308–311. doi:10.1159/000485570
   PubMed Web of Science ®Google Scholar
• Martín JM, Pinazo I, Molina I, et al. Cicatricial pemphigoid of the Brunsting-Perry type. Int J Dermatol. 2009;48:293–294. doi:10.1111/j.1365-4632.2009.03975.x
   PubMed Web of Science ®Google Scholar
• Takeichi S, Kubo Y, Arase S, Hashimoto T, Ansai S. Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure. Eur J Dermatology. 2009;19:500–503. doi:10.1684/ejd.2009.0715
   PubMedGoogle Scholar
• Woźniak K, Kazama T, Kowalewski C. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo bound IgG by laser scanning confocal microscopy. Arch Dermatol. 2003;139:1007–1011. doi:10.1001/archderm.139.8.1007
   PubMedGoogle Scholar
• Sugita Y, Inomata N, Takahashi Y, et al. Autoimmune vesicles on the face and neck. A variant of Brunsting-Perry type localized bullous pemphigoid? Eur J Dermatol. 2001;11:557–559.
   PubMed Web of Science ®Google Scholar
• Minato H, Ishii N, Fukuda S, et al. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa. J Dermatol. 2011;38:887–892. doi:10.1111/j.1346-8138.2010.01172.x
   PubMed Web of Science ®Google Scholar
• Person JR, Rogers RS, Perry HO. Localized pemphigoid. Br J Dermatol. 1976;95:531–534. doi:10.1111/j.1365-2133.1976.tb00864.x
   PubMed Web of Science ®Google Scholar
• Kamaguchi M, Iwata H. The diagnosis and blistering mechanisms of mucous membrane pemphigoid. Front Immunol. 2019;10:34. doi:10.3389/fimmu.2019.00034
   PubMed Web of Science ®Google Scholar
• Fukuda S, Tsuruta D, Uchiyama M, et al. Brunsting-Perry type pemphigoid with IgG autoantibodies to laminin-332, BP230 and desmoplakins I/II. Br J Dermatol. 2011;165:433–435. doi:10.1111/j.1365-2133.2011.10343.x
   PubMed Web of Science ®Google Scholar
• Daito J, Katoh N, Asai J, et al. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180. Br J Dermatol. 2008;159:984–986. doi:10.1111/j.1365-2133.2008.08753.x
   PubMed Web of Science ®Google Scholar
• Tanaka N, Dainichi T, Ohyama B, et al. A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine. J Am Acad Dermatol. 2009;61(4):715–719. doi:10.1016/j.jaad.2008.12.020
   PubMed Web of Science ®Google Scholar
• Joly P, Ruto F, Thomine E, et al. Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? J Am Dermatol. 1993;28(1):89–92
   PubMed Web of Science ®Google Scholar
• Asfour L, Chong H, Mee J, Groves R, Singh M. Epidermolysis bullosa acquisita (Brunsting-Perry Pemphigoid variant) localized to the face and diagnosed with antigen identification using skin deficient in type VII collagen. Am J Dermatopathol. 2017;39:90–96. doi:10.1097/DAD.0000000000000829
   Web of Science ®Google Scholar
• Lee CW, Jun KM. Epidermolysis bullosa acquisita presenting with localized facial blisters. Clin Exp Dermatol. 1992;17:363–365. doi:10.1111/j.1365-2230.1992.tb00234.x
   PubMed Web of Science ®Google Scholar
• Kurzhals G, Stolz W, Meurer M, Kunze J, Kreig T. Acquired epidermolysis bullosa with the clinical features of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol. 1991;127:391–395. doi:10.1001/archderm.1991.01680030111016
   PubMedGoogle Scholar
• Murata Y, Tani M, Kumano K. Localized chronic pemphigoid of Brunsting-Perry ultrastructural localization of IgG and complement components. Arch Dermatol. 1983;119:921–924. doi:10.1001/archderm.1983.01650350049014
   PubMedGoogle Scholar
• Choi GS, Lee E-S, Ch-S K, Lee S. Epidermolysis bullosa acquisita localized to the face. J Dermatol. 1998;25:19–22. doi:10.1111/j.1346-8138.1998.tb02339.x
   PubMedGoogle Scholar
• Demitsu T, Kakurai M, Yoneda K, et al. Localized pemphigoid (Brunsting-Perry type) with IgG antibody to BP180 NC16a domain resembling lupus erythematosus successfully treated with topical tacrolimus therapy. J Eur Acad Dermatol Venereol. 2009;23:79–80. doi:10.1111/j.1468-3083.2008.02702.x
   PubMed Web of Science ®Google Scholar
• Vico-Alonso C, Palencia-Perez S. Linear IgA bullous dermatosis. N Engl J Med. 2020;382(23):2248. doi:10.1056/NEJMicm1913412
   PubMed Web of Science ®Google Scholar
• Lammer J, Hein R, Roenneberg S, et al. Drug-induced linear IgA bullous dermatosis: a case report and review of the literature. Acta Derm Venerolog. 2019;99(6):508–515. doi:10.2340/00015555-3154
   PubMed Web of Science ®Google Scholar
• Diaz MS, Morita L, Ferrari B, et al. Linear IgA bullous dermatosis: a series of 17 cases. Actas dermo-sifiliograficas. 2019;110(8):673–680. doi:10.1016/j.ad.2018.06.017
   PubMed Web of Science ®Google Scholar
• Li Y, Foshee JB, Sontheimer RD. Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease. J Am Acad Dermatol. 2011;64(4):773–778. doi:10.1016/j.jaad.2009.09.045
   PubMed Web of Science ®Google Scholar
• Vorobyev A, Ludwig R, Schmidt E. Clinical features and diagnosis of epidermolysis bullosa simplex. Expert Rev Clin Immunol. 2017;13(2):157–169. doi:10.1080/1744666X.2016.1221343
   PubMed Web of Science ®Google Scholar
• Koga H, Prost-Squarcioni C, Iwata H. Epidermolysis bullosa acquisita: the 2019 update. Front Med. 2019;5:362.
   Web of Science ®Google Scholar
• Rutin S, Chanprapaph K. Vesiculobullous diseases in relation to lupus erythematosus. Clin Cosmet Invest Dermatol. 2019;12:653–667. doi:10.2147/CCID.S220906
   PubMed Web of Science ®Google Scholar
• Bernett CN, Fong M, Rosario-Collazo JA. Linear IGA dermatosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
   Google Scholar